학술논문

Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
Document Type
article
Source
Cell Reports Medicine. 2(2)
Subject
Infectious Diseases
Emerging Infectious Diseases
Biodefense
Pneumonia & Influenza
Vaccine Related
Immunization
Prevention
Lung
Pneumonia
2.1 Biological and endogenous factors
Aetiology
Infection
Good Health and Well Being
CD4+T cells
CD8+ T cells
COVID-19
HLA
SARS-CoV-2
T cells
epitopes
Language
Abstract
T cells are involved in control of SARS-CoV-2 infection. To establish the patterns of immunodominance of different SARS-CoV-2 antigens and precisely measure virus-specific CD4+ and CD8+ T cells, we study epitope-specific T cell responses of 99 convalescent coronavirus disease 2019 (COVID-19) cases. The SARS-CoV-2 proteome is probed using 1,925 peptides spanning the entire genome, ensuring an unbiased coverage of human leukocyte antigen (HLA) alleles for class II responses. For HLA class I, we study an additional 5,600 predicted binding epitopes for 28 prominent HLA class I alleles, accounting for wide global coverage. We identify several hundred HLA-restricted SARS-CoV-2-derived epitopes. Distinct patterns of immunodominance are observed, which differ for CD4+ T cells, CD8+ T cells, and antibodies. The class I and class II epitopes are combined into epitope megapools to facilitate identification and quantification of SARS-CoV-2-specific CD4+ and CD8+ T cells.